Cano Health Q3 2023 Gaap EPS $(91.87) Misses $(18.50) Estimate, Sales $788.07M Beat $757.20M Estimate
Portfolio Pulse from saritha@benzinga.com
Cano Health (NYSE:CANO) reported Q3 2023 GAAP EPS of $(91.87), missing the estimate of $(18.50) by 396.59%. This is a 39843.48% decrease from the same period last year. However, the company's quarterly sales of $788.07M beat the estimate of $757.20M by 4.08%, marking an 18.51% increase from last year.
November 09, 2023 | 10:25 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cano Health's Q3 2023 earnings missed estimates significantly, but sales exceeded expectations.
Cano Health's earnings miss is significant and could negatively impact investor sentiment, potentially leading to a short-term drop in the stock price. However, the sales beat could provide some offsetting positive sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100